Fred Alger Management’s GSK GSK Stock Holding History

Fred Alger Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-21,626	Closed	-$1.19M	–	452
2026 Q1	$1.19M	Buy	+21,626	New	+$1.17M	0.01%	344
2025 Q2	–	Sell	-51,693	Closed	-$2.02M	–	458
2025 Q1	$2.02M	Buy	51,693 +7,390	+17%	+$271K	0.01%	300
2024 Q4	$1.52M	Sell	44,303 -498	-1%	-$17.9K	0.01%	349
2024 Q3	$1.83M	Buy	44,801 +3,733	+9%	+$153K	0.01%	331
2024 Q2	$1.58M	Hold	41,068	–	–	0.01%	335
2024 Q1	$1.76M	Buy	41,068 +7,079	+21%	+$292K	0.01%	353
2023 Q4	$1.26M	Buy	33,989 +2,398	+8%	+$86.1K	0.01%	359
2023 Q3	$1.15M	Hold	31,591	–	–	0.01%	355
2023 Q2	$1.13M	Hold	31,591	–	–	0.01%	375
2023 Q1	$1.12M	Buy	31,591 +1,529	+5%	+$53.5K	0.01%	383
2022 Q4	$1.06M	Buy	30,062 +3,270	+12%	+$109K	0.01%	376
2022 Q3	$788K	Sell	26,792 -194	-0.7%	-$7.35K	﹤0.01%	382
2022 Q2	$1.47M	Buy	26,986 +2,442	+10%	+$135K	0.01%	352
2022 Q1	$1.34M	Buy	24,544 +565	+2%	+$30.7K	﹤0.01%	365
2021 Q4	$1.32M	Buy	23,979 +513	+2%	+$26.7K	﹤0.01%	383
2021 Q3	$1.12M	Hold	23,466	–	–	﹤0.01%	380
2021 Q2	$1.17M	Hold	23,466	–	–	﹤0.01%	384
2021 Q1	$1.05M	Hold	23,466	–	–	﹤0.01%	381
2020 Q4	$1.08M	Hold	23,466	–	–	﹤0.01%	366
2020 Q3	$1.1M	Hold	23,466	–	–	﹤0.01%	336
2020 Q2	$1.2M	Hold	23,466	–	–	﹤0.01%	335
2020 Q1	$1.11M	Sell	23,466 -540	-2%	-$28.8K	﹤0.01%	310
2019 Q4	$1.41M	Hold	24,006	–	–	0.01%	315
2019 Q3	$1.28M	Buy	24,006 +147	+0.6%	+$7.56K	0.01%	315
2019 Q2	$1.19M	Sell	23,859 -6,393	-21%	-$321K	﹤0.01%	328
2019 Q1	$1.58M	Buy	30,252 +3,157	+12%	+$158K	0.01%	297
2018 Q4	$1.29M	Hold	27,095	–	–	0.01%	304
2018 Q3	$1.36M	Hold	27,095	–	–	0.01%	304
2018 Q2	$1.36M	Sell	27,095 -493	-2%	-$24.8K	0.01%	305
2018 Q1	$1.35M	Hold	27,588	–	–	0.01%	316
2017 Q4	$1.22M	Sell	27,588 -3,382	-11%	-$156K	0.01%	319
2017 Q3	$1.57M	Sell	30,970 -419	-1%	-$21.3K	0.01%	301
2017 Q2	$1.69M	Buy	31,389 +6,548	+26%	+$349K	0.01%	298
2017 Q1	$1.31M	Sell	24,841 -22,397	-47%	-$1.14M	0.01%	312
2016 Q4	$2.27M	Sell	47,238 -12,542	-21%	-$620K	0.01%	253
2016 Q3	$3.22M	Buy	59,780 +2,400	+4%	+$132K	0.02%	229
2016 Q2	$3.11M	Buy	57,380 +5,200	+10%	+$274K	0.02%	237
2016 Q1	$2.65M	Buy	52,180 +26,480	+103%	+$1.32M	0.01%	307
2015 Q4	$1.3M	Sell	25,700 -960	-4%	-$48.9K	0.01%	364
2015 Q3	$1.28M	Hold	26,660	–	–	0.01%	375
2015 Q2	$1.39M	Buy	26,660 +8,846	+50%	+$498K	0.01%	407
2015 Q1	$1.03M	Buy	+17,814	New	+$1.02M	﹤0.01%	500

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Fred Alger Management's GSK Position: Q2 2026 in Review

Fred Alger Management sold out of GSK (GSK) in Q2 2026, closing a stake of 21,626 shares — an estimated $1.19M sold.

Fred Alger Management first reported a position in GSK in Q1 2015 and held it in 42 quarters. The position peaked at $3.22M in Q3 2016. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

Fred Alger Management reported no remaining GSK position as of Q2 2026 after selling out during the quarter.
Fred Alger Management sold 21,626 GSK shares in Q2 2026, an estimated $1.19M.
Fred Alger Management first reported a position in GSK in Q1 2015 and held it in 42 quarters.
Fred Alger Management's GSK position peaked at $3.22M in Q3 2016.
1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Fred Alger Management's 13F filing for Q2 2026, filed 14 Aug 2026.